Using AI and health records to improve drug safety for children
Official title: Leveraging artificial intelligence methods and electronic health records for pediatric pharmacovigilance
Funded at Vanderbilt University Medical Center · NIH-10750074 · Data updated 2026-11-12
This study is looking at how safe medications are for kids by using computer technology to analyze health records, so we can better understand any risks or side effects from drugs that moms take during pregnancy and that kids use as they grow up.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $481,250 |
| NIH project number | 1R21HD113234-01 |
| Project ID | NIH-10750074 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include mothers who have used medications during pregnancy and their children, particularly those under 21 years old.
✕Less likely to help
Patients who are not mothers or children, or those who have not been exposed to medications during pregnancy, may not benefit from this research.
What this research studies
This research aims to enhance the understanding of drug safety in pediatric populations by utilizing artificial intelligence and electronic health records. It focuses on analyzing large datasets to identify potential risks, drug interactions, and adverse effects associated with medications used by mothers during pregnancy and by children throughout their development. By conducting extensive studies on mother-child health records, the research seeks to uncover critical information that is often missing due to the lack of clinical trials involving children. This approach will help ensure safer medication practices for pediatric patients.
Why it matters
Potential benefit: If successful, this research could lead to improved safety and efficacy of medications prescribed to children, reducing the risk of adverse drug reactions.
How similar studies have gone: Other research has successfully utilized electronic health records and AI to improve drug safety, indicating that this approach has potential for significant advancements.
Where this research is happening
-
Vanderbilt University Medical Center
Nashville, United States Active
Researchers
- Principal investigator: Bejan, Cosmin Adrian — Vanderbilt University Medical Center
- Study coordinator: Bejan, Cosmin Adrian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.